Publicaciones en colaboración con investigadores/as de Hospital Miguel Servet (23)

2023

  1. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

2022

  1. Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry

    Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 260-266

  2. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

2021

  1. Azole and amphotericin B MIC values against aspergillus fumigatus: High agreement between spectrophotometric and visual readings using the EUCAST EDef 9.3.2 procedure

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1

  2. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7

  3. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2019

  1. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

2018

  1. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis

    Journal of Infection and Chemotherapy, Vol. 24, Núm. 7, pp. 555-562

  2. Production of the invasive aspergillosis biomarker bis(methylthio)gliotoxin Within the genus aspergillus: In vitro and in vivo metabolite quantification and genomic analysis

    Frontiers in Microbiology, Vol. 9, Núm. JUN

2017

  1. Aspergilosis diseminada en un paciente inmunocompetente con bis(metiltio)gliotoxina detectable y galactomanano negativo

    Revista Iberoamericana de Micologia, Vol. 34, Núm. 1, pp. 49-52

  2. Corrigendum: Identification of rare PB2-D701N mutation from a patient with severe influenza: Contribution of the PB2-D701N mutation to the pathogenicity of human influenza [Front. Microbiol. 8, 575 (2017)] doi: 10.3389/fmicb.2017.00575

    Frontiers in Microbiology

  3. Erratum to: “EPICO 3.0. Management of non-neutropenic patients in medical wards” [Rev Iberoam Micol. 33 (4) (2016) 216–223] (S1130140616300365)(10.1016/j.riam.2016.06.003)

    Revista Iberoamericana de Micologia

  4. Identification of rare PB2-D701N mutation from a patient with severe influenza: Contribution of the PB2-D701N mutation to the pathogenicity of human influenza

    Frontiers in Microbiology, Vol. 8, Núm. APR

  5. Infective endocarditis in patients with cancer: A consequence of invasive procedures or a harbinger of neoplasm? A prospective, multicenter cohort

    Medicine (United States), Vol. 96, Núm. 38

2016

  1. Clinical validity of bis(methylthio)gliotoxin for the diagnosis of invasive aspergillosis

    Applied Microbiology and Biotechnology, Vol. 100, Núm. 5, pp. 2327-2334

  2. EPICO 3.0. Management of non-neutropenic patients in medical wards

    Revista Iberoamericana de Micologia, Vol. 33, Núm. 4, pp. 216-223

  3. Evaluation of incubation time for dermatophytes cultures

    Mycoses, Vol. 59, Núm. 7, pp. 416-418

2015

  1. Réplica a «Emergencia de aislados de Mycobacterium tuberculosis complex resistentes a rifampicina y sensibles a isoniazida»

    Enfermedades Infecciosas y Microbiologia Clinica

2013

  1. Incidencia etaria y geográfica y patrón de sensibilidad a los antifúngicos de las especies de Candida causantes de candidemia en la población pediátrica española

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. 6, pp. 363-368

2012

  1. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1181-1187